Pages that link to "Q37119968"
Jump to navigation
Jump to search
The following pages link to HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma (Q37119968):
Displaying 50 items.
- HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy (Q24313419) (← links)
- Systemic therapies for pancreatic cancer--the role of pharmacogenetics (Q27021716) (← links)
- The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development (Q33613335) (← links)
- Pancreatic cancer: molecular pathogenesis and new therapeutic targets (Q33899954) (← links)
- HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels. (Q33917613) (← links)
- EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer (Q34163334) (← links)
- CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy (Q34363535) (← links)
- High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma (Q34721443) (← links)
- HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma (Q34974696) (← links)
- Large-scale determination of absolute phosphorylation stoichiometries in human cells by motif-targeting quantitative proteomics (Q35311600) (← links)
- High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs (Q35437204) (← links)
- The high mobility group A1 molecular switch: turning on cancer - can we turn it off? (Q35504403) (← links)
- Current knowledge on pancreatic cancer (Q35971808) (← links)
- Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma (Q36246425) (← links)
- Critical role of HMGA proteins in cancer cell chemoresistance (Q36308084) (← links)
- The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo. (Q36489812) (← links)
- Apoptotic pathways in pancreatic ductal adenocarcinoma (Q36835642) (← links)
- Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells (Q37223775) (← links)
- Risk factors and therapeutic targets in pancreatic cancer (Q37317310) (← links)
- Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions (Q37392138) (← links)
- HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines (Q37556169) (← links)
- Nuclear functions of the HMG proteins (Q37596093) (← links)
- mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes (Q37726416) (← links)
- Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas (Q37736030) (← links)
- Challenges of drug resistance in the management of pancreatic cancer (Q37799830) (← links)
- Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer—A review (Q37853945) (← links)
- Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression (Q37970379) (← links)
- Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors. (Q38469320) (← links)
- High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy. (Q38807021) (← links)
- Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer (Q38946885) (← links)
- HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells (Q39182492) (← links)
- Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma (Q39542034) (← links)
- Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP–Mediated Expression of HMGA2 (Q39621410) (← links)
- Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. (Q39658359) (← links)
- Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm (Q40499165) (← links)
- Characterization of the Stoichiometry of HMGA1/DNA Complexes (Q41817712) (← links)
- Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes. (Q42826953) (← links)
- Role of high mobility group A1 and body mass index in the prognosis of patients with breast cancer (Q43809683) (← links)
- miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells. (Q47662884) (← links)
- Development of Phosphorothioate DNA and DNA Thioaptamers (Q50893422) (← links)
- HMGA1 expression levels are elevated in pancreatic intraepithelial neoplasia cells in the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer (Q50897116) (← links)
- Adenovirus-Mediated Delivery of Decoy Hyper Binding Sites Targeting Oncogenic HMGA1 Reduces Pancreatic and Liver Cancer Cell Viability. (Q51743664) (← links)
- Mandatory role of HMGA1 in human airway epithelial normal differentiation and post-injury regeneration. (Q52629180) (← links)
- A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy. (Q52692695) (← links)
- Knockdown of HMGA1 expression by short/small hairpin RNA inhibits growth of ovarian carcinoma cells. (Q54324280) (← links)
- HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer. (Q55071062) (← links)
- GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway (Q64060096) (← links)
- Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer (Q84773235) (← links)
- Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma (Q90643218) (← links)
- The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer (Q91715704) (← links)